Miromatrix to Report First Quarter 2022 Financial Results
April 28, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., April 28, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Med
April 19, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., April 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
March 30, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 30, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Moves into New Headquarters Complete with In-House Manufacturing Capabilities
March 29, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 29, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix to Report Fourth Quarter and Full Year 2021 Financial Results
March 17, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix to Participate in CareDx’s Xenotransplantation Innovation Day
March 16, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 16, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Names Jim Douglas as New Chief Financial Officer
March 01, 2022 17:15 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
February 10, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Two New Board Members
January 05, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...